GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
Vesugen 20mg

Vesugen 20mg

Lys-Glu-Asp

CAS: N/A

$71.99$79.9910% OFFIn Stock

Vesugen is a tripeptide bioregulator (Lys-Glu-Asp) derived from vascular tissue. Studied for endothelial homeostasis and vascular aging research. 99.0% HPLC purity.

Specifications

Vial Size20mg
FormLyophilized Powder
Purity99.0% HPLC
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Vascular endothelial tissue-specific gene expression modulation via chromatin interaction. Proposed to support endothelial integrity and vascular wall cell homeostasis.

Research FAQ

What distinguishes Vesugen from Cardiogen?

Cardiogen targets cardiomyocyte (heart muscle) gene expression. Vesugen targets vascular endothelial cells — the lining of blood vessel walls. Adjacent but distinct tissue targets.

Related Compounds